Ping An Biomedical Co., Ltd.
Qualité des données : 100%
PASW
Nasdaq
Manufacturing
Apparel
0,15 €
▲
0,00 €
(0,80%)
Cap. Boursière: 18,00 M
Prix
0,15 €
Cap. Boursière
18,00 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Negative free cash flow of -902 902,0
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-28,36%
Au-dessus de la moyenne du secteur (-53,34%)
ROIC-20,99%
Net Margin-37,57%
Op. Margin-43,05%
Sécurité
Debt / Equity
N/A
Current Ratio0,77
Interest Coverage-47,88
Valorisation
PE (TTM)
-9,99
En dessous de la moyenne du secteur (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -10,0 | -1,5 |
| P/B | — | 1,6 |
| ROE % | -28,4 | -53,3 |
| Net Margin % | -37,6 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
Aucune estimation prévisionnelle disponible
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,80 M | Net Income (TTM) | -1,80 M |
| ROE | -28,36% | ROA | -18,75% |
| Gross Margin | 2,78% | Operating Margin | -43,05% |
| Net Margin | -37,57% | Free Cash Flow (TTM) | -902 902,0 |
| ROIC | -20,99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,77 |
| Interest Coverage | -47,88 | Asset Turnover | 0,50 |
| Working Capital | -1,93 M | Tangible Book Value | -1,62 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -9,99 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 3,75 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -5,02% | ||
| Market Cap | 18,00 M | Enterprise Value | 19,36 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,10 | Revenue / Share | 0,04 |
| FCF / Share | -0,01 | OCF / Share | -0,01 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 50,10% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 |
|---|---|
| Revenue | 4,80 M |
| Net Income | -1,80 M |
| EPS (Diluted) | -0,10 |
| Gross Profit | 133 376,0 |
| Operating Income | -2,07 M |
| EBITDA | — |
| R&D Expenses | — |
| SG&A Expenses | — |
| D&A | — |
| Interest Expense | 43 132,0 |
| Income Tax | 260 653,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 |
|---|---|
| Total Assets | 9,61 M |
| Total Liabilities | 3,26 M |
| Shareholders' Equity | 6,36 M |
| Total Debt | 1,40 M |
| Cash & Equivalents | 164 697,0 |
| Current Assets | 8,95 M |
| Current Liabilities | 3,24 M |
{"event":"ticker_viewed","properties":{"ticker":"PASW","listing_kind":"stock","pathname":"/stocks/pasw","exchange":"Nasdaq","country":"US"}}